Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Multiple Targeting Approaches on Histamine H3 Receptor Antagonists.

Khanfar MA, Affini A, Lutsenko K, Nikolic K, Butini S, Stark H.

Front Neurosci. 2016 May 30;10:201. doi: 10.3389/fnins.2016.00201. eCollection 2016. Review.

2.

Modafinil Moderates the Relationship Between Cancer-Related Fatigue and Depression in 541 Patients Receiving Chemotherapy.

Conley CC, Kamen CS, Heckler CE, Janelsins MC, Morrow GR, Peppone LJ, Scalzo AJ, Gross H, Dakhil S, Mustian KM, Palesh OG.

J Clin Psychopharmacol. 2016 Feb;36(1):82-5. doi: 10.1097/JCP.0000000000000442.

3.

Vincristine-induced unilateral ptosis with serendipitous response to modafinil.

Revannasiddaiah S, Bhattacharyya T.

BMJ Case Rep. 2011 May 3;2011. pii: bcr0720103178. doi: 10.1136/bcr.07.2010.3178.

4.

Practical use and risk of modafinil, a novel waking drug.

Kim D.

Environ Health Toxicol. 2012;27:e2012007. doi: 10.5620/eht.2012.27.e2012007. Epub 2012 Feb 22.

5.

Current perspectives in the management of treatment-resistant depression.

Parikh RM, Lebowitz BD.

Dialogues Clin Neurosci. 2004 Mar;6(1):53-60.

6.

Treatment of HIV-related fatigue with armodafinil: a placebo-controlled randomized trial.

Rabkin JG, McElhiney MC, Rabkin R.

Psychosomatics. 2011 Jul-Aug;52(4):328-36. doi: 10.1016/j.psym.2011.02.005.

7.

Specific treatment of residual fatigue in depressed patients.

Marin H, Menza MA.

Psychiatry (Edgmont). 2004 Sep;1(2):12-8. No abstract available.

8.
9.

Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study.

Rabkin JG, McElhiney MC, Rabkin R, McGrath PJ.

J Clin Psychiatry. 2010 Jun;71(6):707-15. doi: 10.4088/JCP.09m05171bro. Epub 2010 May 4.

10.

Low-dose transdermal testosterone augmentation therapy improves depression severity in women.

Miller KK, Perlis RH, Papakostas GI, Mischoulon D, Losifescu DV, Brick DJ, Fava M.

CNS Spectr. 2009 Dec;14(12):688-94.

11.

A retrospective review of supratherapeutic modafinil exposures.

Carstairs SD, Urquhart A, Hoffman J, Clark RF, Cantrell FL.

J Med Toxicol. 2010 Sep;6(3):307-10. doi: 10.1007/s13181-010-0017-6.

12.

Treatment strategies to improve and sustain remission in major depressive disorder.

Trivedi MH, Daly EJ.

Dialogues Clin Neurosci. 2008;10(4):377-84. Review.

13.

A placebo-controlled trial of modafinil for nicotine dependence.

Schnoll RA, Wileyto EP, Pinto A, Leone F, Gariti P, Siegel S, Perkins KA, Dackis C, Heitjan DF, Berrettini W, Lerman C.

Drug Alcohol Depend. 2008 Nov 1;98(1-2):86-93. doi: 10.1016/j.drugalcdep.2008.04.008. Epub 2008 Jun 9.

14.

Treatment of narcolepsy and other hypersomnias of central origin.

Wise MS, Arand DL, Auger RR, Brooks SN, Watson NF; American Academy of Sleep Medicine.

Sleep. 2007 Dec;30(12):1712-27. Review.

15.

Treatments in depression.

Duval F, Lebowitz BD, Macher JP.

Dialogues Clin Neurosci. 2006;8(2):191-206. Review.

16.

Modafinil as an adjunctive treatment to sleep deprivation in depression.

Even C, Thuile J, Santos J, Bourgin P.

J Psychiatry Neurosci. 2005 Nov;30(6):432-3.

17.

Modafinil in sports: ethical considerations.

Kaufman KR.

Br J Sports Med. 2005 Apr;39(4):241-4; discussion 241-4.

18.

Modafinil Treatment of Excessive Daytime Sedation and Fatigue Associated With Topiramate.

Berigan TR.

Prim Care Companion J Clin Psychiatry. 2002 Dec;4(6):249-250. No abstract available.

19.

Augmentation With Modafinil to Achieve Remission in Depression: A Case Report.

Berigan TR.

Prim Care Companion J Clin Psychiatry. 2001 Feb;3(1):32. No abstract available.

Supplemental Content

Support Center